New AI device improves early cancer detection

Hospitals are embracing AI technology, which has shown to improve cancer detection rates and enhance patient outcomes.
AI technology in UK hospitals is boosting early detection of bowel lesions, significantly aiding in cancer prevention.

South Tyneside and Sunderland NHS Foundation Trust will continue using AI technology after a successful trial demonstrated its effectiveness in identifying bowel lesions. The trial involved 2,032 patients across 10 centres in the UK and used the GI Genius AI device during colonoscopies. After a while, this technology detected an additional 0.36 adenomas per procedure, helping to prevent potential cancer development.

Professor Colin Rees, a consultant gastroenterologist at the trust, highlighted the significance of the AI device in saving lives by increasing the detection of bowel abnormalities. The AI was particularly effective in identifying small or flat polyps often missed by the human eye, which can be crucial in early cancer prevention.

Bowel cancer remains a significant health concern in the UK, with 43,000 new cases and 16,000 deaths annually. The AI’s ability to detect adenomas in an extra eight out of 100 people without increasing complications is a promising advancement for medical professionals.

The trial, led by South Tyneside and Sunderland NHS Foundation Trust and Newcastle University, has encouraged the trust to integrate AI technology into routine practice. As the AI continues to learn from images, its performance is expected to improve further, offering hope for wider adoption in the future.